Timothy L Frankel Selected Research

Timothy L Frankel Research Topics

Disease

21	Neoplasms (Cancer) 01/2022 - 09/2008
7	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 12/2010
6	Neoplasm Metastasis (Metastasis) 01/2021 - 12/2010
4	Adenocarcinoma 01/2022 - 11/2020
3	Colonic Neoplasms (Colon Cancer) 09/2019 - 03/2012
3	Melanoma (Melanoma, Malignant) 08/2010 - 04/2010
2	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2020
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2020
2	Hemorrhage 03/2005 - 07/2003
1	Bites and Stings (Sting) 01/2022
1	COVID-19 01/2021
1	Metaplasia 01/2020
1	Carcinogenesis 01/2020
1	Microsatellite Instability 09/2019
1	Pancreatitis 01/2019
1	Hepatocellular Carcinoma (Hepatoma) 02/2015
1	Margins of Excision 10/2013
1	Paraneoplastic Syndromes (Paraneoplastic Syndrome) 08/2010
1	Extranodal Extension 09/2008
1	Postoperative Hemorrhage 03/2005
1	Mediastinitis 07/2003
1	Cardiac Tamponade 07/2003

Drug/Important Bio-Agent (IBA)

5	Immune Checkpoint InhibitorsIBA 01/2022 - 11/2018
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2010
3	LigandsIBA 01/2021 - 12/2018
2	Phosphotransferases (Kinase)IBA 01/2022 - 08/2019
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2017
2	InterferonsIBA 01/2022 - 08/2019
2	RNA (Ribonucleic Acid)IBA 01/2021 - 11/2020
2	AntigensIBA 01/2011 - 04/2010
1	RNA Polymerase IIIIBA 01/2022
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Tryptophan (L-Tryptophan)FDA Link 01/2022
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2022
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2022
1	B7-H1 AntigenIBA 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	peposertibIBA 01/2022
1	DNA-Activated Protein KinaseIBA 01/2022
1	Biocompatible Materials (Biomaterials)IBA 01/2021
1	Complement System Proteins (Complement)IBA 01/2021
1	Antineoplastic Agents (Antineoplastics)IBA 01/2021
1	sonidegibIBA 01/2021
1	ChemokinesIBA 01/2020
1	ruxolitinibIBA 01/2020
1	trametinibIBA 01/2020
1	Interleukin-22 (IL-22)IBA 01/2020
1	InterleukinsIBA 01/2020
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	atezolizumabIBA 01/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020
1	beta CateninIBA 01/2020
1	Janus KinasesIBA 01/2020
1	CCR1 ReceptorsIBA 01/2020
1	ParaffinIBA 09/2019
1	Formaldehyde (Formol)FDA Link 09/2019
1	Interferon Type IIBA 08/2019
1	Gemcitabine FDA Link 01/2019
1	Heparin-binding EGF-like Growth Factor (HB-EGF)IBA 01/2019
1	CeruletideIBA 01/2019
1	PyrimidinesIBA 01/2019
1	Tamoxifen FDA LinkGeneric 01/2019
1	GABA-A Receptors (GABA(A) Receptor)IBA 12/2018
1	Glutamine (L-Glutamine)FDA Link 09/2016
1	Contrast MediaIBA 03/2012
1	HLA-A*02:01 antigenIBA 01/2011
1	EpitopesIBA 01/2011
1	IpilimumabIBA 12/2010
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 12/2010
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 08/2010
1	Monophenol Monooxygenase (Tyrosinase)IBA 06/2010
1	Melanins (Melanin)IBA 06/2010
1	EnzymesIBA 06/2010
1	DisulfidesIBA 06/2010
1	CytokinesIBA 06/2010
1	Histocompatibility Antigens Class IIBA 04/2010
1	Chimeric Antigen ReceptorsIBA 04/2010
1	HLA Antigens (Human Leukocyte Antigens)IBA 04/2010
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 04/2010
1	HMW-MAAIBA 04/2010
1	baysilon (polydimethylsiloxane)IBA 07/2003

Therapy/Procedure

10	Therapeutics 01/2022 - 04/2010
6	Immunotherapy 01/2022 - 04/2010
2	Metastasectomy 01/2020 - 03/2012
1	Continuity of Patient Care 01/2021
1	Adjuvant Radiotherapy 01/2021
1	Radiotherapy 01/2020
1	Image-Guided Radiotherapy 01/2020
1	Contraindications 07/2015
1	Pancreatectomy 10/2013
1	Lymph Node Excision (Lymph Node Dissection) 09/2008
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 03/2005
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 03/2005
1	Blood Transfusion (Blood Transfusions) 03/2005
1	Chest Tubes (Chest Tube) 07/2003